Damaging variants in FOXI3 cause microtia and craniofacial microsomia.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
01 2023
Historique:
received: 01 07 2022
revised: 11 09 2022
accepted: 12 09 2022
pubmed: 20 10 2022
medline: 11 1 2023
entrez: 19 10 2022
Statut: ppublish

Résumé

Craniofacial microsomia (CFM) represents a spectrum of craniofacial malformations, ranging from isolated microtia with or without aural atresia to underdevelopment of the mandible, maxilla, orbit, facial soft tissue, and/or facial nerve. The genetic causes of CFM remain largely unknown. We performed genome sequencing and linkage analysis in patients and families with microtia and CFM of unknown genetic etiology. The functional consequences of damaging missense variants were evaluated through expression of wild-type and mutant proteins in vitro. We studied a 5-generation kindred with microtia, identifying a missense variant in FOXI3 (p.Arg236Trp) as the cause of disease (logarithm of the odds = 3.33). We subsequently identified 6 individuals from 3 additional kindreds with microtia-CFM spectrum phenotypes harboring damaging variants in FOXI3, a regulator of ectodermal and neural crest development. Missense variants in the nuclear localization sequence were identified in cases with isolated microtia with aural atresia and found to affect subcellular localization of FOXI3. Loss of function variants were found in patients with microtia and mandibular hypoplasia (CFM), suggesting dosage sensitivity of FOXI3. Damaging variants in FOXI3 are the second most frequent genetic cause of CFM, causing 1% of all cases, including 13% of familial cases in our cohort.

Identifiants

pubmed: 36260083
pii: S1098-3600(22)00941-8
doi: 10.1016/j.gim.2022.09.005
pmc: PMC9885525
mid: NIHMS1864558
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-150

Subventions

Organisme : NIDCD NIH HHS
ID : R00 DC011282
Pays : United States
Organisme : NIDCR NIH HHS
ID : U01 DE025862
Pays : United States
Organisme : NIDCR NIH HHS
ID : RC1 DE020270
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no conflicts of interest.

Références

Am J Med Genet A. 2015 Mar;167A(3):537-44
pubmed: 25655429
Science. 2008 Sep 12;321(5895):1462
pubmed: 18787161
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Clin Plast Surg. 2019 Apr;46(2):207-221
pubmed: 30851752
Eur J Med Genet. 2014 Aug;57(8):394-401
pubmed: 24880027
Nat Commun. 2021 Aug 3;12(1):4680
pubmed: 34344887
Differentiation. 2020 Sep - Oct;115:30-36
pubmed: 32858261
J Allergy Clin Immunol. 2020 Jan;145(1):358-367.e2
pubmed: 31600545
Dev Biol. 2014 Jun 1;390(1):1-13
pubmed: 24650709
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2203928119
pubmed: 35584116
Dev Biol. 2016 Jan 1;409(1):139-151
pubmed: 26550799
Sci Rep. 2018 Nov 22;8(1):17249
pubmed: 30467319

Auteurs

Daniel Quiat (D)

Department of Cardiology, Boston Children's Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Department of Genetics, Harvard Medical School, Boston, MA.

Andrew T Timberlake (AT)

Hansjörg Wyss Department of Plastic and Reconstructive Surgery, NYU Langone Medical Center, New York, NY.

Justin J Curran (JJ)

Department of Genetics, Harvard Medical School, Boston, MA.

Michael L Cunningham (ML)

Division of Craniofacial Medicine, Department of Pediatrics, University of Washington, Seattle, WA; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA.

Barbara McDonough (B)

Department of Genetics, Harvard Medical School, Boston, MA.

Maria A Artunduaga (MA)

Respira Labs, Inc, Mountain View, CA.

Steven R DePalma (SR)

Department of Genetics, Harvard Medical School, Boston, MA.

Milagros M Duenas-Roque (MM)

Hospital Edgardo Rebagliati Martins, EsSalud, Lima, Peru.

Joshua M Gorham (JM)

Department of Genetics, Harvard Medical School, Boston, MA.

Jonas A Gustafson (JA)

Division of Craniofacial Medicine, Department of Pediatrics, University of Washington, Seattle, WA.

Usama Hamdan (U)

Global Smile Foundation, Norwood, MA.

Anne V Hing (AV)

Division of Craniofacial Medicine, Department of Pediatrics, University of Washington, Seattle, WA; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA.

Paula Hurtado-Villa (P)

Pontificia Universidad Javeriana and Centro Médico Imbanaco, Cali, Colombia.

Yamileth Nicolau (Y)

Texas ENT Specialists, Houston, TX.

Gabriel Osorno (G)

Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.

Harry Pachajoa (H)

Servicio de Genética Médica, Fundación Valle del Lili, Cali, Colombia; Centro de Investigación en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Icesi, Cali, Colombia.

Gloria L Porras-Hurtado (GL)

Clinica Comfamiliar Risaralda, Pereira, Colombia.

Lourdes Quintanilla-Dieck (L)

Department of Otolaryngology Head and Neck Surgery, Oregon Health & Science University, Portland, OR.

Luis Serrano (L)

Audiocentro, Cuenca, Ecuador.

Melissa Tumblin (M)

Ear Community, Inc, Broomfield, CO.

Ignacio Zarante (I)

Human Genomics Institute, Pontificia Universidad Javeriana, Bogotá, Colombia; Hospital Universitario San Ignacio, Bogotá, Colombia.

Daniela V Luquetti (DV)

Division of Craniofacial Medicine, Department of Pediatrics, University of Washington, Seattle, WA; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA.

Roland D Eavey (RD)

Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, TN. Electronic address: ron.eavey@vumc.org.

Carrie L Heike (CL)

Division of Craniofacial Medicine, Department of Pediatrics, University of Washington, Seattle, WA; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA. Electronic address: carrie.heike@seattlechildrens.org.

Jonathan G Seidman (JG)

Department of Genetics, Harvard Medical School, Boston, MA. Electronic address: seidman@genetics.med.harvard.edu.

Christine E Seidman (CE)

Department of Genetics, Harvard Medical School, Boston, MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA; Howard Hughes Medical Institute, Chevy Chase, MD. Electronic address: cseidman@genetics.med.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH